Reducing the risk of obesity: defining the role of weight loss drugs.
about
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to dateObjective assessment of changes in physical activity and sedentary behavior: Pre- through 3 years post-bariatric surgery.Ferulic acid lowers body weight and visceral fat accumulation via modulation of enzymatic, hormonal and inflammatory changes in a mouse model of high-fat diet-induced obesityPeripheral targets in obesity treatment: a comprehensive update.Pig fat, pork bellies, and portly appearance.Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy
P2860
Reducing the risk of obesity: defining the role of weight loss drugs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Reducing the risk of obesity: defining the role of weight loss drugs.
@en
type
label
Reducing the risk of obesity: defining the role of weight loss drugs.
@en
prefLabel
Reducing the risk of obesity: defining the role of weight loss drugs.
@en
P2093
P2860
P356
P1433
P1476
Reducing the risk of obesity: defining the role of weight loss drugs.
@en
P2093
Daniel E Hilleman
Tammy L Burns
Thomas L Lenz
P2860
P304
P356
10.1002/PHAR.1277
P407
P577
2013-05-26T00:00:00Z